Competition Appellate Tribunal (COMPAT) directs re-consideration by CCI against movie producers/distributors for alleged cartelisation in setting unfair standards in cinema exhibition

COMPAT, by its order dated December 08, 2015 reversed the order of CCI dated April 22, 2015 which closed a case without initiating investigation against the 7 movie producers/distributors engaged in the production/distribution of Hollywood movies. The case was filed by K. Sera Sera Digital Cinema Pvt. Ltd alleging that the 7 opposite parties(OPs) compelled…

Bid Rigging Cartels In Public Procurement: Some Evolving Trends In Indian Competition Law

“Though the loose standard of proof of preponderance of probability adopted by CCI so far has been repeatedly questioned in the appeals against penalty orders of CCI, two recentdecisions of closure of alleged bid rigging in railway supplies by acceptance of objective justifications by parties isa suresign of a maturing and evolving jurisprudence of the…

Impact Of Competition Law On Indian Real-Estate Sector- An Analysis Of The Recent Order Against Dlf

In the wake of economic liberalization and widespread economic reforms introduced in India since 1991 and in its attempt to march from a “Command and Control” regime to a regime based on free market principles, India  replaced   its archaic Monopolies and Restrictive Practices Act, 1969 with a modern competition law, in sync with modern and…

Need for National Competition Policy

Recently, in news published in the Financial Express on 11th August 2010, the Competition Commission of India (CCI) is reported to have issued wide ranging recommendations to the Planning Commission for incorporation in the proposed National Competition Policy. The recommendations relating to the electricity sector, as reported, include, inter-alia, review on policies of imposition of…

No Fair-Play in Pharma Industry

November 3, 2009 The recent anti-trust raids on Ranbaxy’s France unit by the European Commission (EC) has not come as a surprise, given that most pharmaceutical companies in India manufacture generic drugs. These drugs contain same active ingredients as the original formulations invented by the “originator” companies, mostly from Europe or United States, and in…